Cytostatic activity of coumarin metabolites and derivatives in the B16-F10 murine melanoma cell line

被引:46
作者
Jiménez-Orozco, FA
Molina-Guarneros, JA
Mendoza-Patiño, N
León-Cedeño, F
Flores-Pérez, B
Santos-Santos, E
Mandoki, JJ
机构
[1] Univ Nacl Autonoma Mexico, Fac Med, Dept Farmacol, Mexico City 04510, DF, Mexico
[2] Univ Nacl Autonoma Mexico, Fac Quim, Dept Quim Organ, Mexico City 04510, DF, Mexico
关键词
coumarin derivatives; growth inhibition; melanoma cells;
D O I
10.1097/00008390-199906000-00005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Coumarin has antitumour effects in vivo and cytostatic effects in vitro. Its half-life in humans is short (1-1.5 h) and the monohydroxylated biotransformation products have significantly longer half-lives. One or several of these products may thus be responsible for the antitumoral effects. We have assayed the in vitro cytostatic activity of five monohydroxylated coumarins (3-, 4-, 6-, 7- and 8-monohydroxycoumarin), their acetates and methyl-ethers. Murine melanoma cells (cell line B16-F10) and murine fibroblasts (B82) were exposed to the test compounds at concentrations between 10 and 160 mu g/ml. The cytostatic effects were estimated by reduction of the tetrazolium dye MTT. In the melanoma cells, some of the compounds inhibited growth after exposure for 1 day. In contrast, coumarin inhibited growth to a smaller extent, and only after exposure for 3 days. The most active compounds (3-acetoxycoumarin, 4-methoxycoumarin and 6-hydroxycoumarin), as well as coumarin, were also assayed in murine fibroblasts. The cytostatic effects of 4-methoxycoumarin and 6-hydroxycoumarin were less pronounced in fibroblasts than in melanoma cells. Our observations suggest that these compounds may have a greater therapeutic margin. (C) 1999 Lippincoti Williams & Wilkins.
引用
收藏
页码:243 / 247
页数:5
相关论文
共 26 条
[1]   PREPARATION AND REACTIONS OF ORTHO-HYDROXYCINNAMIC ACIDS AND ESTERS [J].
ADAMS, R ;
BOCKSTAHLER, TE .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1952, 74 (21) :5346-5348
[2]  
[Anonymous], J CANC RES CLIN ONCO
[3]   CRITICAL-REVIEW OF THE TOXICOLOGY OF COUMARIN WITH SPECIAL REFERENCE TO INTERSPECIES DIFFERENCES IN METABOLISM AND HEPATOTOXIC RESPONSE AND THEIR SIGNIFICANCE TO MAN [J].
COHEN, AJ .
FOOD AND COSMETICS TOXICOLOGY, 1979, 17 (03) :277-289
[4]   THE RARITY OF LIVER TOXICITY IN PATIENTS TREATED WITH COUMARIN (1,2-BENZOPYRONE) [J].
COX, D ;
OKENNEDY, R ;
THORNES, RD .
HUMAN TOXICOLOGY, 1989, 8 (06) :501-506
[5]   THE PHARMACOLOGY, METABOLISM, ANALYSIS, AND APPLICATIONS OF COUMARIN AND COUMARIN-RELATED COMPOUNDS [J].
EGAN, D ;
OKENNEDY, R ;
MORAN, E ;
COX, D ;
PROSSER, E ;
THORNES, RD .
DRUG METABOLISM REVIEWS, 1990, 22 (05) :503-529
[6]  
Furniss B. S, 1978, VOGELS TXB PRACTICAL, P755
[7]  
FURNISS BS, 1978, VOGELS TXB PRACTICAL, P493
[8]   4-DIALKYLAMINOPYRIDINES AS ACYLATION CATALYSTS .3. ACYLATION OF STERICALLY HINDERED ALCOHOLS [J].
HOFLE, G ;
STEGLICH, W .
SYNTHESIS-INTERNATIONAL JOURNAL OF METHODS IN SYNTHETIC ORGANIC CHEMISTRY, 1972, (11) :619-&
[9]  
Jones G., 1967, ORGANICREACTIONS, V15, P204, DOI [DOI 10.1002/0471264180.OR015.02, 10.1002/0471264180.or015.02]
[10]  
KAHN J, 1994, J CANC RES CLIN ON S, V120, P19